Table 2.
Summary of case reports identified in literature search.
| Age/sex | Terminology | Time after mTORi initiation | Presenting symptoms | Diagnosis | IS treatment | Action mTORi | Outcome | |
|---|---|---|---|---|---|---|---|---|
| Kidney transplantation | ||||||||
| Amigues et al. 2005 [10] | 48/M | Infiltrative pneumonia | 1 month | Dyspnea, cough, and fever | CXR and HRCT | SRL + TAC + P | Disc. | Resolved |
| Bankar et al. 2006 [11] | 56/M | Interstitial pneumonitis | 2 months | Dyspnea and cough | CXR and HRCT | SRL + MMF | Disc. | Resolved |
| Calle et al. 2009 [12] | 64/F | Interstitial pneumonitis | 4.5 years | Dyspnea | CXR, Chest CAT | SRL + MPA + steroids | Switch to EVR | Improved |
| Chen et al. 2003 [13] | 43/F | Interstitial pneumonia | Within 1 month | Cough and hemoptysis | CXR and HRCT | SRL (adjuvant) + CsA + MMF + MP | Disc. | Improved |
| Chhajed et al. 2006 [14] | 65/F | Pneumonitis | 3 months | Dyspnea and cough | CXR, CT, and TBB | SRL + TAC + P | Disc. | Improved |
| 48/F | Pneumonitis | 8 months | Dyspnea | CXR, CT, and TBB | SRL + TAC + AZA + P | Disc. | Resolved | |
| 61/M | Organizing pneumonia | 2 years | Dyspnea, cough, fever, and hemoptysis | CXR, CT, and TBB | SRL + AZA | Disc. | Resolved | |
| Filippone et al. 2011 [15] | 61/M | Pneumonitis | 6 years | Dyspnea and pleuritic chest pain | CT, bronchoscopy, and open lung biopsy | SRL + MMF + P | Disc. | Improved |
| Haydar et al. 2004 [16] | 49/M | BOOP | 18 months | Dyspnea and cough | CXR, CT, and bronchoscopy | SRL + CsA + P | Disc. | Resolved |
| 54/M | Pneumonitis | 16 months | Dyspnea | HRCT and TBB | SRL | Disc. | Resolved | |
| 63/M | Pneumonitis | 7 months | Dyspnea, cough, and fever | CXR and HRCT | SRL + AZA + P | Disc. | Resolved | |
| Huang et al. 2013 [17] | 65/F | Pneumonitis | 17 months | Dyspnea, cough, and fever | CXR, CT, and bronchoscopy | SRL + MMF + TAC + P | Disc. | Improved |
| 64/F | Pneumonitis | 2 years | Dyspnea and cough | CXR and CT | SRL + MMF + TAC + P | Disc. | Improved | |
| Kadikoy et al. 2010 [18] | 49/F | PAP | 3 years | Dyspnea and cough | CXR, CT, and bronchoscopy | SRL + MPA + P | Disc. | Improved |
| Kanaan et al. 2008 [19] | 64/M | Interstitial pneumonitis | 2 weeks | Dyspnea, cough, and fever | CXR and HRCT | SRL | Disc. | Resolved |
| Kirby et al. 2012 [20] | 31/M | Organizing pneumonia | — | Dyspnea and cough | CT and TBB | SRL + MPA + CsA + P | Disc. | Improved |
| Mingos and Kane 2005 [21] | 30/F | Interstitial pneumonitis | 6 months | Dyspnea, cough, fever, and chest pain | Noncontrast CT and TBB | SRL + P | Disc. | Resolved |
| Morath et al. 2007 [22] | 61/M | Interstitial pneumonitis | 6 weeks | Dyspnea and fever | CXR, CT, and TBB | SRL + MP | Disc. | Improved |
| 67/M | Lymphocytic alveolitis | 2 weeks | Dyspnea and cough | CXR, HRCT, and TBB | SRL + MMF + MP | Disc. | Resolved | |
| 62/M | Interstitial pneumonitis | 2 weeks | Dyspnea, cough, and fever | CXR and CT | SRL + MP | Disc. | Improved | |
| 42/F | Interstitial pneumonitis | 2 years | Dyspnea | CXR and CT | SRL + TAC + MP | Disc. | Improved | |
| Nayak et al. 2004 [23] | 54/M | Pneumonitis | 2 months | Dyspnea | CXR and CT | SRL + MMF + P | Disc. | Resolved |
| Pedroso et al. 2007 [24] | 34/F | PAP | 2 years | Dyspnea, cough, fever, chest and pain | CXR, CT, and bronchoscopy | SRL + MMF + steroids | Disc. | Resolved |
| Pham et al. 2004 [25] | 57/F | Pulmonary toxicity | 2.5 months | Dyspnea, chills, and night sweats | CXR, HRCT, and wedge biopsy | SRL + low-dose TAC + P | Disc. | Improved |
| 42/F | Pulmonary toxicity | 2.5 months | Dyspnea and fever | CXR, HRCT, and TBB | SRL + low dose CsA + P | Disc. | Improved | |
| 55/F | Pulmonary toxicity | 4 months | Dyspnea, cough, and hemoptysis | CXR, HRCT, and TBB | SRL + TAC | Disc. | Improved | |
| Rehm et al. 2006 [26] | 61/M | Pneumonitis | — | Dyspnea, fever, and pulmonary infiltrates | CXR, CT, and TBB | SRL + AZA + P | Switch to EVR | Improved |
| 55/F | Alveolitis obliterans | — | Dyspnea and cough | Bronchoscopy | SRL + MMF | Switch to CsA + MPA followed by EVR + MPA | Improved | |
| 63/M | Allergic pneumonitis | — | Pulmonary symptoms | CXR and bronchoscopy | SRL + MMF | Switch to EVR | Improved | |
| 51/F | Allergic interstitial pneumonitis | — | Cough and fever | TBB | SRL + MMF | Switch to EVR | Improved | |
| 65/M | Lymphocytic alveolitis | — | — | TBB | SRL + MMF | Switch to EVR†† | Improved | |
| Sajjad et al. 2006 [27] | 79/M | Interstitial lung disease | — | Dyspnea, cough, and chills | CXR, CT, HRCT, and TBB | SRL + P | Disc. | Improved |
| Shefet et al. 2004 [28] | 51/F | Interstitial pneumonitis | 11 months | Bilateral infiltrates chest X-ray | TBB | SRL + TAC + P | Disc. | Improved |
| Singh et al. 2009 [29] | 15/F | Pneumonitis | 4 years | Dyspnea | CT, bronchoscopy, and pulmonary biopsy | SRL + MMF | Disc. | Resolved |
| Ussavarungsi et al. 2012 [30] | 53/F | Granulomatous pneumonitis | 2 months | Dyspnea, fever, and hypoxia | CXR, CT, and thoracoscopic biopsy | SRL + CsA | Disc. | Improved |
| Carreño and Gadea 2007 [31] | 56/F | BOOP | 2 months | Dyspnea, cough, and fever | CXR and bronchoscopy | EVR | No action | Resolved |
| Alexandru et al. 2008 [32] | 57/M | Pharmacological pneumonitis | 3 months | Dyspnea, cough, and fever | CXR, CT, and lung biopsy | EVR + MMF | Disc. | Improved |
| Bouvier et al. 2009 [33] | 74/M | Hypersensitivity pneumonitis | 1 year | Dyspnea, cough, and fever | CXR, CT, and TBB | EVR | Disc. | Improved |
| Kurnatowska et al. 2010 [34] | 59/F | Interstitial pneumonitis | 6 weeks | Dyspnea and cough | HRCT and TBB | EVR + MMF + steroids | Disc. | Resolved |
| González et al. 2010 [35] | 70/M | Interstitial pneumonitis | 4 months | Dyspnea, cough, and fever | CXR, CT, and bronchoscopy | EVR + MPA + steroids | Disc. | Improved |
| Sułkowska et al. 2012 [36] | 30/M | Pneumonitis | 5 days | Dyspnea, fever, sore throat, desaturation, and respiratory insufficiency | CXR, HRCT, and TBB | EVR + MPA + P | Disc. | Resolved |
|
| ||||||||
| Heart transplantation | ||||||||
| Chau and Chow 2006 [37] | 47/M | Pneumonitis | 3 months | Dyspnea, cough, and fever | CXR and HRCT | SRL + CsA + P | Disc. | Resolved |
| Delgado et al. 2006 [38] | 58/M | Interstitial pneumonitis | 3 years | Dyspnea and cough | CXR and HRCT | SRL + CsA + MMF + P | Disc. | Improved |
| 66/M | Interstitial pneumonitis | 2 months | Cough and respiratory insufficiency | CXR and HRCT | SRL + MMF + P | Disc. | Resolved | |
| 65/M | Interstitial pneumonitis | 1.5 year | Cough and fever | HRCT | SRL + MMF + P | Disc. | Resolved | |
| García-Luque et al. 2008 [39] | 70/M | Interstitial pneumonitis | 2 months | Dyspnea, cough, fever, and chest pain | CXR and HRCT | SRL + MMF | Disc. | Improved |
| 62/F | Interstitial pneumonitis | 10 months | Dyspnea, cough, and fever | CXR and HRCT | SRL + MMF | Disc. | Improved | |
| 55/M | Interstitial pneumonitis | 4 months | Fever and cough | CXR, HRCT | SRL + MMF | Disc. | Improved | |
| Garrean et al. 2005 [40] | 64/F | Pulmonary toxicity | 2 weeks | Dyspnea, fever, and hemoptysis | CXR, CT, and bronchoscopy | SRL + MPA + P | — | Death |
| Hamour et al. 2006 [41] | 59/M | Pneumonitis | Progressively during 2 months | Dyspnea and fever | CXR, HRCT | SRL + CsA | Disc. | Resolved |
| Manito et al. 2004 [42] | 52/M | Interstitial pneumonitis | 10 days | Respiratory distress | CXR | SRL + MMF + P | Dose red. and disc. | Death |
| McWilliams et al. 2003* [43] | 32/M | Organizing pneumonia/pneumonitis | 1 month | Dyspnea and lung function restriction | CXR, HRCT, and TBB | SRL + P | Disc. | Improved |
| David et al. 2007 [44] | 71/M | Bronchiolitis obliterans | — | Fever and respiratory symptoms | HRCT | EVR + MMF + P | Disc. | Improved |
| Expsito et al. 2008 [45] | 45/M | Organizing pneumonia | 4 months | Dyspnea, cough, fever, and pleuritic chest pain | CXR, CT, and TBB | EVR + AZA + P | Disc. | Improved |
| 66/M | Organizing pneumonia | 2 months | Cough, fever, and pleuritic chest pain | CXR and TBB | EVR + AZA | Disc. | Improved | |
| Otton et al. 2009 [46] | 32/M | Pneumonitis | 2 weeks | Dyspnea | CXR, CT, and bronchoscopy | EVR + CsA + MMF + P | Disc. | Improved |
| 68/M | Pneumonitis | 3 months | Dyspnea and hemoptysis | CXR, HRCT, and bronchoscopy | EVR + CsA + MMF + P | Disc. | Improved. Second episode after EVR reinstitution | |
| 60/M | Pneumonitis | 6 months | Dyspnea | HRCT | EVR + AZA + CsA + P | Disc. | Improved | |
|
| ||||||||
| Liver transplantation | ||||||||
| Avitzur et al. 2003 [47] | 8/F | Interstitial granulomatous pneumonitis + PTLD | 9 months | Dyspnea | CXR, CT, and open lung biopsy | SRL with CsA tapering and discontinuation | Disc. | Improved |
| De Simone et al. 2007 [48] | 62/F | Pneumonitis | 9 months | Dyspnea and fever | CXR | SRL monotherapy | Switch to EVR | Resolved |
| Feagans et al. 2009 [49] | 55/M | Pulmonary toxicity | 8 months | Dyspnea, cough, and fever | CXR, CT, and lung biopsy | SRL + CsA + steroids | Disc. | Resolved |
| 60/M | Pulmonary toxicity | 37 months | Dyspnea, cough, and fever | CXR and CT | SRL + MPA + P | Disc. | Improved | |
| Gupte et al. 2007† [50] | 2/F | Pulmonary toxicity | 5 months | Dyspnea and cough | CXR and HRCT | SRL + TAC + P | Disc. | Improved |
| 9 month/M | Pulmonary toxicity | 7 months | Dyspnea and cough | CXR and HRCT | SRL + TAC + P | Disc. | Improved | |
| Howard et al. 2006 [51] | 73/F | Pulmonary hypersensitivity | 2 weeks | Dyspnea and cough | CXR, CT, and TBB | SRL + AZA + P | Disc. | Resolved |
| Lennon et al. 2001 [52] | 49/M | Pneumonitis | 5 months | Dyspnea and cough | CXR and CT | SRL + AZA + steroids | Disc. | Resolved |
| Prez et al. 2007 [53] | 62/M | Interstitial pneumonitis | 3 months | Dyspnea, cough, and fever | CXR and CT | SRL + MMF + steroids | Disc. | Resolved |
| Schrader et al. 2010 [54] | 63/F | Bronchiolitis obliterans | 2 months | Dyspnea | CT, bronchoscopy, and peripheral lung biopsy | EVR + stepwise reduction of CsA + MMF + steroids | Disc. | Resolved |
*Heart-lung transplantation; †Combined small bowel and liver transplantation; ††EVR discontinued due to relapsing allergic pneumonitis.
AZA, azathioprine; BOOP, bronchiolitis obliterans organizing pneumonia; CAT, computed axial tomography; CsA, cyclosporine; CT, computed tomography; CXR, chest X-ray; Disc., discontinued; EVR, everolimus; HRCT, high resolution computed tomography; MMF, mycophenolate mofetil; MPA, mycophenolate; MP, methylprednisolone; mTORi, mammalian target of rapamycin inhibitor; P, prednisolone; PAP, pulmonary alveolar proteinosis; PTLD, posttransplant lymphoproliferative disorder; SRL, sirolimus; TAC, tacrolimus; TBB, transbronchial biopsy.